88 related articles for article (PubMed ID: 9246423)
1. Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study.
Tsatsakis AM; Psillakis TK; Tzatzarakis M; Kourtopoulos H; Paritsis N
Clin Chim Acta; 1997 Jul; 263(2):187-95. PubMed ID: 9246423
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine levels in head hair of patients under long-term treatment: a method to evaluate the history of drug use.
Psillakis T; Tsatsakis AM; Christodoulou P; Michalodimitrakis M; Paritsis N; Helidonis E
J Clin Pharmacol; 1999 Jan; 39(1):55-67. PubMed ID: 9987701
[TBL] [Abstract][Full Text] [Related]
3. Determination of phenytoin in sections of head hair: a preliminary study to evaluate the history of drug use.
Tsatsakis AM; Psillakis T; Stefis A; Assithianakis P; Vlahonikolis IG; Michalodimitrakis MN; Helidonis E
Boll Chim Farm; 1998 Dec; 137(11):459-66. PubMed ID: 10077879
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin concentration in head hair sections: a method to evaluate the history of drug use.
Tsatsakis AM; Psillakis T; Paritsis N
J Clin Psychopharmacol; 2000 Oct; 20(5):560-73. PubMed ID: 11001242
[TBL] [Abstract][Full Text] [Related]
5. Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring?
Kintz P; Marescaux C; Mangin P
Hum Exp Toxicol; 1995 Oct; 14(10):812-5. PubMed ID: 8562122
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a noninstrumented immunoassay for carbamazepine to high performance liquid chromatography and fluorescence polarization immunoassay.
Cochran EB; Massey KL; Phelps SJ; Cramer JA; Toftness BR; Denio LS; Drake ME
Epilepsia; 1990; 31(4):480-4. PubMed ID: 2369881
[TBL] [Abstract][Full Text] [Related]
7. Is a "color effect" demonstrated for hair analysis of carbamazepine?
Mieczkowski T
Life Sci; 2000 May; 67(1):39-43. PubMed ID: 10896027
[TBL] [Abstract][Full Text] [Related]
8. Effect of vigabatrin on the pharmacokinetics of carbamazepine.
Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I; Llopis P
J Clin Pharm Ther; 2002 Dec; 27(6):427-30. PubMed ID: 12472982
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of carbamazepine and metabolites in human hair.
Saris LA; Brekelmans GJ; van der Linden GJ; Rademaker RV; Edelbroek PM
J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):409-15. PubMed ID: 9174278
[TBL] [Abstract][Full Text] [Related]
10. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy.
Williams J; Patsalos PN; Wilson JF
Forensic Sci Int; 1997 Jan; 84(1-3):113-22. PubMed ID: 9042715
[TBL] [Abstract][Full Text] [Related]
11. Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population.
Williams J; Patsalos PN; Mei Z; Schapel G; Wilson JF; Richens A
Ther Drug Monit; 2001 Feb; 23(1):15-20. PubMed ID: 11206037
[TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.
Nag D; Garg RK; Agarwal A
J Assoc Physicians India; 1998 Feb; 46(2):185-8. PubMed ID: 11273108
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and pharmacokinetics of carbamazepine oral loading doses.
Cohen H; Howland MA; Luciano DJ; Rubin RN; Kutt H; Hoffman RS; Leung LK; Devinsky O; Goldfrank LR
Am J Health Syst Pharm; 1998 Jun; 55(11):1134-40. PubMed ID: 9626375
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of antiepileptic drugs by gas chromatography using capillary or packed columns and by fluorescence polarization immunoassay.
Chen K; Khayam-Bashi H
J Anal Toxicol; 1991; 15(2):82-5. PubMed ID: 2051749
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
20. Free drug levels monitoring as a detector of false metabolic refractory epilepsy.
Gianelli M; Gentile S; Verzè L; Dimanico U; Baruchello M; Monaco F; Mutani R
Eur Neurol; 1988; 28(6):349-53. PubMed ID: 3215211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
